Skip to main content

Table 2 Baseline, cardiac arrest times, ECMO run and outcome characteristics of ECPR patients, in-hospital versus out-of-hospital cardiac arrest

From: The effect of restrictive versus liberal selection criteria on survival in ECPR: a retrospective analysis of a multi-regional dataset

Characteristics

Total (n = 199)

In-hospital (n = 104)

Out of hospital (n = 95)

P-value

Age, yr, mean (SD)

50.5 (15.2)

52.6 (16.0)

48.2 (14.1)

0.02

Female, n (%)

48 (24.1)

33 (31.7)

15 (15.8)

0.009

Comorbidities, n (%)

    

Diabetes type 1 or 2

33 (16.6)

23 (22.1)

10 (10.5)

0.028

Chronic kidney disease CKD 1–3

9 (4.5)

9 (8.7)

0 (0)

0.003

Heart failure (NYHA 1 or 2)

8 (4.0)

6 (5.7)

2 (2.1)

0.19

Peripheral vascular disease

5 (2.5)

4 (3.8)

1(1.0)

0.21

Ischaemic heart disease (prior to admission)

29 (14.6)

21 (20.2)

8 (8.4)

0.019

Cardiac intervention prior (PCI, CABG, other)

40 (20.1)

34 (32.7)

6 (6.3)

< 0.001

COPD (Stage 3 or less)

5 (2.5)

4 (3.9)

1 (1.0)

0.21

Chronic liver disease (Child–Pugh A or less)

3 (1.5)

1 (1.0)

2 (2.1)

0.53

Cardiac arrest and ECMO run

CPR in progress at ECMO initiation, n (%)

187 (94)

98 (94.2)

89 (93.7)

0.87

Shockable initial rhythm, n (%)

103 (53.7)

35 (35.7)

68 (72.3)

< 0.001

Any ROSC, n (%)

86 (43.2)

46 (44.2)

40 (42.1)

0.76

Bystander CPR performed, n (%)

191 (96.0)

104 (100)

87 (91.6)

0.003

Witnessed arrest, n (%)

185 (93.0)

100 (96.2)

85 (89.5)

0.066

Duration of cardiac arrest* at arrival of ECMO provider, min, median, (IQR)

30 (8–51)

10 (5–25)

50 (43–66)

< 0.001

Time for decision, set up, cannulation, min, median, (IQR)

22 (16–35)

21 (13–35)

25 (20–34)

0.022

Total time to ECMO support, min, median, (IQR)

59 (35–82)

39 (24–53)

77 (68–95)

< 0.001

Outcome

Coronary angiogram performed, n (%)

120 (60.3)

53 (51.0)

67 (70.5)

0.005

Cardiac therapeutic intervention, n (%)

Percutaneous coronary intervention** review

65 (32.7)

26 (25.0)

39 (41.1)

0.016

Cardiac bypass surgery

13 (6.5)

10 (9.6)

3 (3.1)

0.066

AICD

13 (6.5)

9 (8.67

4 (4.2)

0.21

Other

26 (13.1)

17 (16.4)

9 (9.5)

0.15

ECMO weaned sucessfully, n (%)

88 (44.2)

63 (60.6)

25 (26.3)

< 0.001

ECMO duration (weaned), d, median (IQR)

4 (2–7)

5 (2–8)

4 (2–6)

0.54

Bridge to LVAD, n (%)

5 (2.5)

4 (3.9)

1 (1.0)

0.21

Bridge to heart transplant, n (%)

4 (2.0)

1 (1.0)

3 (3.2)

0.27

Survival to hospital discharge, n (%)

62 (31.2)

43 (41.4)

19 (20.0)

0.001

CPC of survivors at discharge, total n = 62, n (%)

1

51 (82.2)

38 (88.4)

13 (68.4)

 

2

9 (14.5)

5 (11.6)

4 (21.1)

 

3

1 (1.6)

0 (0)

1 (5.3)

 

4

0 (0)

0 (0)

0 (0)

 

Uncertain CPC

1 (1.6)

0 (0)

1 (5.3)

 

Organ donation, n (%)

14 (7.0)

3 (2.9)

11 (11.6)

0.017

  1. *cardiac arrest time refers to the longest arrest time with or without ROSC < 20 min
  2. SD Standard deviation, IQR Interquartile range, CKD Chronic kidney disease, NYHA New York Heart Association, PCI Percutaneous coronary intervention, CABG Coronary artery bypass grafting, COPD Chronic obstructive pulmonary disease, ROSC Return of spontaneous circulation, CPR Cardiopulmonary resuscitation, ECMO Extracorporeal membrane oxygenation, LVAD Left ventricular assist device, AICD Automated internal cardiac defibrillator, CPC Cerebral performance category